BigHat Biosciences raised a $75 million Series C co-led by DFJ Growth and Premji Invest to advance its clinical-stage pipeline and expand its data platform.
- Amount
- $75M
- Stage
- Series C
- Announced
- 24 September 2026
- Leads
- DFJ Growth, Premji Invest
- Use of funds
- Advancing BigHat's clinical-stage pipeline and growing its data platform
- Checked
- Amount and date checked against the press source